1Ferenci P, I.ockwood A, Mullen K, et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11^th World Congresses of Gastroenterology, Vienna. Hcpatology, 1998, 35:716-721.
2Cordoba J, Blei AT. Hepatic encephalopathy, in Schiff ER, Sortell MF, Maddrey WC(eds): Schiff's Diseases of the Liver. Phila delphia, Lippincott Williams & Wilkins, 2003, 595-623.
3Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic: mechanisms. Pro Sec Ex Med, 1999,222:99-112.
4Jones EA. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab Brain Dis, 2002,17 : 275-281.
5Suarez I, Bodega G, Fernandez B. Glutamine synthesis in brain: effect of ammonia. Neuroehem Int, 2002,41: 123-142.
8Vaseonez C, Elizalde JI, Llach J, et al. Helicobacter pylori, hyperammonemia and subclinical porto-systemic encephalopathy: effects of eradication. J Hepatol, 1999,30:260-264.
9Basile AS, Harrison PM, Hughes RD, et al. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology, 1993: 112-121.
10Ahboucha S, Butterworth RF. Pathophysiotogy of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metah Brain Dis, 2004(19) 1331-343.
